| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 111-115, Copyright © 1995 by Endocrine Society
ARTICLES |
AI Blakemore, PF Watson, AP Weetman and GW Duff
Department of Medicine and Pharmacology, University of Sheffield, Royal Hallamshire Hospital, United Kingdom.
The proinflammatory cytokine, interleukin-1 (IL-1), has been implicated in the pathogenesis of several autoimmune and inflammatory diseases. One of its natural inhibitors, IL-1 receptor antagonist, is a potent antiinflammatory agent. We have previously described genetic associations between an allele of the IL-1 receptor antagonist gene (IL1RN*2) and several autoimmune and inflammatory diseases. In the present study, we tested the association of this polymorphism with thyroid diseases. We genotyped 2 separate cohorts (total of 100 patients) with Graves' disease and 58 patients with Hashimoto's thyroiditis and compared IL1RN*2 frequencies with those in 261 ethnically matched controls. There was a significant increase in IL1RN*2 frequency and carriage rate in Graves' disease, but this was not associated with thyroid antibody levels, T4 levels, thyroid- associated ophthalmopathy, or outcome after antithyroid drug treatment. In contrast, there was no difference in the frequency of IL1RN*2 between patients with Hashimoto's thyroiditis and the control group. Whether the IL1RN polymorphism makes a direct functional contribution to the pathogenesis of Graves' disease or is acting as a marker for a linked gene is being investigated.
This article has been cited by other articles:
 |
|
 |
|
  M. Hayashi, T. Kouki, N. Takasu, S. Sunagawa, and I. Komiya Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients. Eur. J. Endocrinol., June 1, 2008; 158(6): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Awomoyi, M. Charurat, A. Marchant, E. N. Miller, J. M. Blackwell, K. P.W.J. McAdam, and M. J. Newport Polymorphism in IL1B: IL1B--511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1{beta} in IFN-{gamma} primed ex-vivo whole blood assay Innate Immunity, October 1, 2005; 11(5): 281 - 286. [Abstract] [PDF]
|
|
|
|
 |
|
 B. S. Prabhakar, R. S. Bahn, and T. J. Smith Current Perspective on the Pathogenesis of Graves' Disease and Ophthalmopathy Endocr. Rev., December 1, 2003; 24(6): 802 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tomer and T. F. Davies Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function Endocr. Rev., October 1, 2003; 24(5): 694 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Kacem, A. Rebai, N. Kaffel, S. Masmoudi, M. Abid, and H. Ayadi PDS Is a New Susceptibility Gene to Autoimmune Thyroid Diseases: Association and Linkage Study J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2274 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jin, W. Teng, S. Ben, X. Xiong, J. Zhang, S. Xu, Y. Y. Shugart, L. Jin, J. Chen, and W. Huang Genome-Wide Scan of Graves' Disease: Evidence for Linkage on Chromosome 5q31 in Chinese Han Pedigrees J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1798 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Vaidya, P. Kendall-Taylor, and S. H. S. Pearce The Genetics of Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5385 - 5397. [Full Text] [PDF]
|
|
|
|
 |
|
 L Joos, L McIntyre, J Ruan, J E Connett, N R Anthonisen, T D Weir, P D Pare, and A J Sandford Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers Thorax, November 1, 2001; 56(11): 863 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Hunt, S. E. Marshall, A. P. Weetman, J. I. Bell, J. A. H. Wass, and K. I. Welsh Cytokine Gene Polymorphisms in Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1984 - 1988. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Vaidya, H. Imrie, P. Perros, E. T. Young, W. F. Kelly, D. Carr, D. M. Large, A. D. Toft, M. I. McCarthy, P. Kendall-Taylor, et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus Hum. Mol. Genet., July 1, 1999; 8(7): 1195 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Andus, R Daig, D Vogl, E Aschenbrenner, G Lock, S Hollerbach, M Kollinger, J Scholmerich, and V Gross Imbalance of the interleukin 1 system in colonic mucosa---association with intestinal inflammation and interleukin 1 receptor agonist genotype 2 Gut, November 1, 1997; 41(5): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
